Intensity Modulated Proton Therapy for Hepatocellular Carcinoma: Initial Clinical Experience
R.S. Bhangoo(Mayo Clinic Hospital), Christopher L. Hallemeier(Mayo Clinic in Arizona), Sunil Krishnan(Smith Family), Terence T. Sio(The University of Texas MD Anderson Cancer Center), William G. Rule(Mayo Clinic in Arizona), Trey C. Mullikin(Cancer Institute (WIA)), T.A. DeWees(Mayo Clinic in Arizona), Satomi Shiraishi(Mayo Clinic), Michael A. Golafshar, Michael G. Haddock(Mayo Clinic in Arizona), Kenneth W. Merrell(Mayo Clinic), Jonathan B. Ashman(Mayo Clinic in Arizona), Wei Liu(WinnMed), Tiffany Cheng(Mayo Clinic in Florida), Yanle Hu(Mayo Clinic in Florida), J. Johnson(Mayo Clinic)
Cited by 26
Related Papers
Cholangiocarcinoma — evolving concepts and therapeutic strategies
|Nature Reviews Clinical Oncology|2017|1.7k
Non–Small Cell Lung Cancer, Version 4.2024
|Journal of the National Comprehensive Cancer Network|2024|746